Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LOW
|
Jennifer L Weber
EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct | 2,279 Reduced 9.19% |
$183,277
$80.42 p/Share
|
Apr 01
2020 |
|
LMT
|
James O Ellis Jr
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 552 Reduced 100.0% |
$186,863
$338.52 p/Share
|
Apr 01
2020 |
|
LMT
|
James O Ellis Jr
Director |
BUY
Exercise of conversion of derivative security
|
Indirect | 552 Added 50.0% |
-
|
Apr 01
2020 |
|
CVS
|
Larry J Merlo
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 8,868 Reduced 1.71% |
$517,359
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Eva C Boratto
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 887 Reduced 1.26% |
$51,748
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Eva C Boratto
EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 887 Reduced 1.26% |
$51,748
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Thomas M Moriarty
EVP & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,806 Reduced 2.77% |
$105,362
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,552 Reduced 1.49% |
$90,544
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Lisa Bisaccia
Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,109 Reduced 2.42% |
$64,699
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Alan Lotvin
EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct | 1,481 Reduced 12.72% |
$86,402
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Joshua Matthew Flum
EVP, ENT STRATEGY & DIGITAL |
SELL
Payment of exercise price or tax liability
|
Direct | 973 Reduced 3.75% |
$56,765
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
Jonathan E. Mayhew
EVP - Transformation |
SELL
Payment of exercise price or tax liability
|
Direct | 763 Reduced 4.75% |
$44,513
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
James David Clark
SVP, Cont & Chief Acct Officer |
BUY
Grant, award, or other acquisition
|
Direct | 7,713 Added 27.63% |
$449,976
$58.34 p/Share
|
Apr 01
2020 |
|
CVS
|
James David Clark
SVP, Cont & Chief Acct Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 681 Reduced 5.67% |
$39,730
$58.34 p/Share
|
Apr 01
2020 |
|
TXN
|
Michael D. Hsu
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,064 Added 50.0% |
-
|
Apr 01
2020 |
|
SPWR
|
Total S.A.
Director |
BUY
Open market or private purchase
|
Indirect | 720,585 Added 0.83% |
$3,422,779
$4.75 p/Share
|
Apr 01
2020 |
|
INTC
|
Navin Shenoy
EVP, GM - Data Platforms Group |
SELL
Open market or private sale
|
Direct | 10,935 Reduced 12.75% |
$577,477
$52.81 p/Share
|
Apr 01
2020 |
|
TMUS
|
John J Legere
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,372,236 Added 31.06% |
-
|
Apr 01
2020 |
|
TMUS
|
John J Legere
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 593,492 Reduced 19.49% |
$50,523,972
$85.13 p/Share
|
Apr 01
2020 |
|
TMUS
|
Stephen R Kappes
Director |
BUY
Grant, award, or other acquisition
|
Direct | 508 Added 5.4% |
-
|
Apr 01
2020 |
|
ABT
|
Andrew H Lane
EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct | 365 Reduced 0.55% |
$28,802
$78.91 p/Share
|
Apr 01
2020 |
|
ABT
|
Andrew H Lane
EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 1,659 Added 2.45% |
-
|
Apr 01
2020 |
|
ABT
|
Christopher J Scoggins
SENIOR VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct | 1,048 Reduced 2.55% |
$82,698
$78.91 p/Share
|
Apr 01
2020 |
|
ABT
|
Randel William Woodgrift
SENIOR VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct | 1,368 Reduced 2.54% |
$107,949
$78.91 p/Share
|
Apr 01
2020 |
|
DAL
|
Berkshire Hathaway Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 7,747,766 Reduced 3.71% |
$194,623,888
$25.12 p/Share
|
Apr 01
2020 |
|
AAPL
|
Luca Maestri
Senior Vice President, CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 44,616 Reduced 39.4% |
$10,748,441
$240.91 p/Share
|
Apr 01
2020 |
|
AAPL
|
Luca Maestri
Senior Vice President, CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 85,678 Added 43.07% |
-
|
Apr 01
2020 |
|
AAPL
|
Jeffrey E Williams
COO |
SELL
Payment of exercise price or tax liability
|
Direct | 44,616 Reduced 23.0% |
$10,748,441
$240.91 p/Share
|
Apr 01
2020 |
|
AAPL
|
Jeffrey E Williams
COO |
BUY
Exercise of conversion of derivative security
|
Direct | 85,678 Added 30.63% |
-
|
Apr 01
2020 |
|
UNH
|
William C Ballard Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 216 Added 0.35% |
-
|
Apr 01
2020 |
|
UNH
|
Richard T Burke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 216 Added 0.14% |
-
|
Apr 01
2020 |
|
UNH
|
Timothy Patrick Flynn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 348 Added 5.02% |
-
|
Apr 01
2020 |
|
UNH
|
Stephen J Hemsley
CEO, UHG |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 0.06% |
-
|
Apr 01
2020 |
|
UNH
|
Michele J Hooper
Director |
BUY
Grant, award, or other acquisition
|
Direct | 216 Added 0.61% |
-
|
Apr 01
2020 |
|
UNH
|
Frederick William Mcnabb Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 348 Added 3.62% |
-
|
Apr 01
2020 |
|
UNH
|
Rice Valerie Md Montgomery
Director |
BUY
Grant, award, or other acquisition
|
Direct | 282 Added 11.13% |
-
|
Apr 01
2020 |
|
UNH
|
John H Noseworthy
Director |
BUY
Grant, award, or other acquisition
|
Direct | 348 Added 18.37% |
-
|
Apr 01
2020 |
|
UNH
|
Glenn M Renwick
Director |
BUY
Grant, award, or other acquisition
|
Direct | 374 Added 0.45% |
-
|
Apr 01
2020 |
|
UNH
|
Gail R Wilensky |
BUY
Grant, award, or other acquisition
|
Direct | 216 Added 0.93% |
-
|
Apr 01
2020 |
|
EVRI
|
Michael D Rumbolz
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 507 Reduced 0.26% |
$1,399
$2.76 p/Share
|
Apr 01
2020 |
|
EVRI
|
Michael D Rumbolz
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 2,083 Added 1.08% |
-
|
Apr 01
2020 |
|
NBHC
|
Whitney A. Bartelli
Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 837 Added 19.96% |
-
|
Apr 01
2020 |
|
NBHC
|
Zsolt K Bessko
Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,477 Added 8.02% |
-
|
Apr 01
2020 |
|
NBHC
|
Aldis Birkans
PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct | 3,772 Added 21.23% |
-
|
Apr 01
2020 |
|
NBHC
|
G. Timothy Laney
CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 13,636 Added 2.19% |
-
|
Apr 01
2020 |
|
NBHC
|
Richard U Newfield Jr.
CHIEF RISK MNGMT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 4,139 Added 3.44% |
-
|
Apr 01
2020 |
|
NBHC
|
Christopher S. Randall
EVP, COMM. & SPECIALTY BANKING |
BUY
Grant, award, or other acquisition
|
Direct | 1,948 Added 12.1% |
-
|
Apr 01
2020 |
|
NBHC
|
Patrick G. Sobers |
BUY
Grant, award, or other acquisition
|
Direct | 1,607 Added 10.24% |
-
|
Apr 01
2020 |
|
NBHC
|
Ruth Stevenson
CHIEF CLIENT EXECUTIVE |
BUY
Grant, award, or other acquisition
|
Direct | 740 Added 3.98% |
-
|
Apr 01
2020 |
|
NBHC
|
Nicole Van Denabeele
CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct | 779 Added 26.52% |
-
|
Apr 01
2020 |